Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Organigram Global Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of OGI: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders73169−3
Shares7.88M9567.62M−256.5K (−3.3%)
Value$10.6M$1.28K$7.87M−$2.77M (−26.0%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Organigram Global Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to OGI in Q2 2026
InstitutionSharesValue% of portfolio
Old Mission Capital LLC147,136$150.1K0.00%
HRT Financial LP91,212$93.0K0.00%
Citigroup Inc20,438$20.8K0.00%
Millennium Management LLC17,363$17.7K0.00%
Two Sigma Securities, LLC11,610$11.8K0.00%
Ameritas Advisory Services, LLC2,278$2.32K0.00%
McDonald Partners LLC50$510.00%
Axiom Investment Management LLC31$320.00%
Action Point Financial Planning, LLC7$70.00%

Sold out (12)

Institutions that held Organigram Global Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (1)

Institutions that held Organigram Global Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC956$1.28K